Feasibility of quality of life assessment in patients with upper gastrointestinal tract cancer

British Journal of Cancer

Volumn 89, Issue 3, 2003, Pages 497-501

  Blazeby, J M ^a,b   Nicklin, J ^a   Brookes, S T ^b   Winstone, K ^a   Alderson, D ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Compliance; EORTC QLQ C30; Quality of life; Upper gastrointestinal cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; GASTRECTOMY; HEALTH CARE NEED; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRE; STOMACH CANCER; TELEPHONE; TREATMENT OUTCOME; UPPER GASTROINTESTINAL TRACT; ESOPHAGUS TUMOR; EVALUATION; FEASIBILITY STUDY; INFORMATION PROCESSING; LONGITUDINAL STUDY; MIDDLE AGED; NURSE PATIENT RELATIONSHIP; PSYCHOLOGICAL ASPECT; REPRODUCIBILITY; SOCIAL CLASS; STOMACH TUMOR;

AGED; DATA COLLECTION; ESOPHAGEAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NURSE-PATIENT RELATIONS; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SOCIAL CLASS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 0042978490     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601146     Document Type: Article

References (21)

1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, De Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PE, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Nat Cancer Inst 85: 365-376
2. Barr H, Krasner N (1991) Prospective quality-of-life analysis after palliative photoablation for the treatment of malignant dysphagia. Cancer 68: 1660-1664
3. Bernhard J, Sullivan M, Hurny C, Coates AS, Rudenstam CM (2001) Clinical relevance of single item quality of life indicators in cancer clinical trials. Br J Cancer 84: 1156-1165
4. Blazeby JM, Alderson D, Winstone K, Steyn R, Hammerlid E, Arraras J, Farndon JR, on behalf of the EORTC Quality of Life Study Group (1996) Development of a EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. Eur J Cancer 32: 1912-1917
5. Blazeby JM, Conroy T, Hammerlid E, Fayers P, Sezer O, Koller M, Arraras J, Bottomley A, Vickery CW, Etienne PL, Alderson D (2003) Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 39: 1384-1394
6. De Haes JCJM, Curran D, Young T, Bottomley A, Flechtner H, Aaronson NK, Blazeby JM, Bjordal K, Brandberg Y, Greimel E, Maher EJ, Sprangers MAG, Cull A, on behalf of the EORTC Quality of Life Group (2000) Quality of life evaluation in oncological clinical trials - the EORTC model. Eur J Cancer 36: 821-825
7. Detmar SB, Aaronson NK (1998) Quality of life assessment in daily clinical oncology practise: a feasibility study. Eur J Cancer 34: 1181-1186
8. Detmar SB, Aaronson NK, Wever LD, Muller M, Schornagel JH (2000) How are you feeling? Who wants to know? Patients' and oncologists' preferences for discussing health-related quality-of-life issues. J Clin Oncol 18: 3295-3301
9. Hearn J, Higginson IJ (1997) Outcome measures in palliative care for advanced cancer patients: a review. J Public Health Med 19: 193-199
10. Ilson DH, Saltz L, Enzinger P, Huang Y, Kornblith A, Gollub M, O'Reilly E, Schwartz G, DeGroff J, Gonzalez G, Kelsen DP (1999) Phase 2 trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol 17: 3270-3275
11. Kiebert G, Wait S, Bernhard J, Bezjak A, Cella D, Ray D, Houghton J, Moinpour C, Scott C, Stephens R (2001) Practice and policy of measuring quality of life and health economics in cancer clinical trials: a survey among co-operative trial groups. Qual Life Res 9: 1073-1080
12. Lee CW, Chi KN (2000) The standard of reporting of health-related quality of life in clinical cancer trials. J Clin Epidemiol 53: 451-458
13. Nordin K, Steel J, Hoffman K, Glimelius B (2001) Alternative methods of interpreting quality of life data in advanced gastrointestinal cancer patients. Br J Cancer 85: 1265-1272
14. Ross P, Nicolson M, Cunningham D, Valle J, Seymour M, Harper P, Price T, Anderson H, Iveson T, Hickish T, Lofts F, Norman A (2002) Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 20: 1996-2004
15. Sanders C, Egger M, Donovan JL, Tallon D, Frankel S (1998) Reporting on quality of life in randomised controlled trials: bibliographic study. Br Med J 317: 1191-1194
16. Sloan J (2002) Asking the obvious questions regarding patient burden. J Clin Oncol 20: 4-6
17. Spencer GM, Thorpe SM, Blackman GM, Solano J, Tobias JS, Lovat LB, Bown SG (2002) Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study. Gut 50: 224-227
18. The American Society of Clinical Oncology (1996) Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 14: 671-679
19. Velikova G, Brown JM, Smith AB, Selby PJ (2002) Computer-based quality of life questionnaires may contribute to doctor-patient interactions in oncology. Br J Cancer 86: 51-59
20. Vickery CW, Blazeby JM, Conroy T, Arraras J, Sezer O, Roller M, Rosemeyer D, Johnson C, Alderson D, on behalf of the EORTC Quality of Life Group (2001) Development of an EORTC disease specific quality of life module for use in patients with gastric cancer. Eur J Cancer 966-971
21. Webb A, Cunningham D, Scarffe JH, Norman A, Joffe JK, Hughes M, Mansi J, Findlay M, Hill A, Gates J, Nicholson M, Kickish T, O'Brien M, Iveson T, Watson M, Underbill C, Wardley A, Meehan M (1997) Randomised trial comparing epirubicin, cisplatin and fluorouracil versus fluorouracil, doxorubicin and methrotrexate in advanced oesophagogastric cancer. J Clin Oncol 15: 261-267